Case Report

Combined Haploidentical Hematopoetic Stem Cell Transplantation and Liver Transplantation in a Pediatric Patient

Abstract

Solid organ transplantation from the same donor is an established procedure for end-stage organ failure that developed after a previous hematopoietic stem cell transplantation (HSCT); however, it is rarely done in patients transplanted with unmanipulated haplo-HSCT. There are no pediatric reports regarding the long-term performance of organ transplantation after haplo-HSCT with post-transplant cyclophosphamide (PTCY).
A juvenile myelomonocytic leukemia patient, who underwent unmanipulated haplo-HSCT with PTCY from her mother at the age of 3 years, developed chronic liver graft versus host disease (GvHD) which was refractory to specific GvHD treatment. Liver transplantation (LT) from her mother (the donor of her haplo-HSCT) was decided as the next line of treatment.
LT was performed on day 540 post-HSCT, and the donor's left lateral segment was appropriately removed and attached to the recipient. The symptoms of GvHD completely regressed in a month. The patient died on day 121 after LT, because of a possible hepato-pulmonary syndrome.
Organ failure can develop after allo-HSCT secondary to GvHD and therefore performing HSCT from a haplo-donor may be superior to a matched unrelated donor in terms of subsequent organ transplantation for organ failure.

1. Strober S. Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants. Blood. 2016;127(12):1539-43.
2. Mahr B, Granofszky N, Muckenhuber M, et al. Transplantation Tolerance through Hematopoietic Chimerism: Progress and Challenges for Clinical Translation. Front Immunol. 2017;8:1762.
3. Rao AS, Fontes P, Zeevi A, et al. Combined bone marrow and whole organ transplantation from the same donor. Transplant Proc. 1994;26(6):3377-8.
4. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353-61
5. Doney KC, Mielcarek M, Stewart FM, et al. Hematopoietic Cell Transplantation after Solid Organ Transplantation. Biol Blood Marrow Transplant. 2015;21(12):2123-2128.
6. Chen YB, Elias N, Heher E, et al. Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure. Blood. 2019;134(2):211-215.
7. Fangmann J, Kathrin Al-Ali H, Sack U, et al. Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant. 2011;11(1):156-62.
8. Brockmann JG, Broering DC, Raza SM, et al. Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature. Bone Marrow Transplant. 2019;54(2):190-203.
9. Doucette K, Shah NJ, Donato ML, et al. Immune tolerance with combined allogeneic haplo-identical haematopoietic stem cell transplant and renal transplant. Br J Haematol. 2021;194(4):779-783.
10. Jacobsen N, Taaning E, Ladefoged J, et al. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet. 1994;343(8900):800.
11. Matsuzaki A, Suminoe A, Koga Y, et al. Lung transplantation after hematopoietic stem cell transplantation from the same living donor in a child with juvenile myelomonocytic leukemia and bronchiolitis obliterans. Pediatr Blood Cancer. 2008;51(4):567.
12. Shah N, Vesole AS, Donate ML, et al. Successful Renal Transplant Tolerance Following a Haplo-Identical Allogenic Hematopoietic Stem Cell Transplant - a Case Report and Review of Literature. Blood. 2016;128(22):5879.
13. Nayyar D, Man HS, Granton J, et al. Defining and characterizing severe hypoxemia after liver transplantation in hepatopulmonary syndrome. Liver Transpl. 2014;20(2):182-90.
14. Koenecke C, Hertenstein B, Schetelig J, et al. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT. Am J Transplant. 2010;10(8):1897-906.
15. Ma L, Han X, Jiang S, et al. Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis. Hematology. 2020;25(1):356-365.
16. Saglio F, Berger M, Spadea M, et al. Haploidentical HSCT with post transplantation cyclophosphamide versus unrelated donor HSCT in pediatric patients affected by acute leukemia. Bone Marrow Transplant. 2021;56(3):586-595.
17. Patzer L, Ringelmann F, Kentouche K, et al. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant. 2001;27(3):319-27.
18. Saddadi F, Hakemi M, Najafi I, et al. Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes. Transplant Proc. 2009;41(7):2895-7.
19. Dudek AZ, Mahaseth H, DeFor TE, et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant. 2003;9(10):657-66.
Files
IssueVol 17, No 4 (2023) QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/ijhoscr.v17i4.13921
Keywords
Post-transplant cyclophosphamide; Liver transplantation; Hematopoetic stem cell transplantation
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Uygun V, Aliosmanoğlu İbrahim, Daloğlu H, öztürkmen S, yalçın K, Karasu G, Yeşilipek A. Combined Haploidentical Hematopoetic Stem Cell Transplantation and Liver Transplantation in a Pediatric Patient. Int J Hematol Oncol Stem Cell Res. 2023;17(4):291-295.